Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters
- PMID: 9669506
- DOI: 10.1016/s0014-2999(98)00241-6
Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters
Abstract
In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [3H]cyanoimipramine and [3H]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter (Ki = 74 nM) and a very low affinity for the norepinephrine transporter (Ki = 1.26 microM). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [3H]cyanoimipramine and [3H]nisoxetine binding sites.
Similar articles
-
Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects.Brain Res. 1996 Oct 14;736(1-2):287-96. doi: 10.1016/0006-8993(96)00713-5. Brain Res. 1996. PMID: 8930335
-
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors.Neuropsychopharmacology. 2001 Dec;25(6):871-80. doi: 10.1016/S0893-133X(01)00298-6. Neuropsychopharmacology. 2001. PMID: 11750180
-
Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.Synapse. 1999 Jun 1;32(3):198-211. doi: 10.1002/(SICI)1098-2396(19990601)32:3<198::AID-SYN6>3.0.CO;2-2. Synapse. 1999. PMID: 10340630
-
Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.Cell Mol Neurobiol. 1999 Aug;19(4):467-89. doi: 10.1023/a:1006986824213. Cell Mol Neurobiol. 1999. PMID: 10379421 Free PMC article. Review.
-
Neuropharmacology of paroxetine.Psychopharmacol Bull. 2003 Spring;37 Suppl 1:8-18. Psychopharmacol Bull. 2003. PMID: 14566196 Review.
Cited by
-
Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes.Br J Pharmacol. 2009 Dec;158(7):1848-56. doi: 10.1111/j.1476-5381.2009.00478.x. Br J Pharmacol. 2009. PMID: 19912224 Free PMC article.
-
Precision Medicine in Antidepressants Treatment.Handb Exp Pharmacol. 2023;280:131-186. doi: 10.1007/164_2023_654. Handb Exp Pharmacol. 2023. PMID: 37195310 Review.
-
Architectonic distribution of the serotonin transporter within the orbitofrontal cortex of the vervet monkey.Neuroscience. 2007 Sep 21;148(4):937-48. doi: 10.1016/j.neuroscience.2007.06.038. Epub 2007 Jul 17. Neuroscience. 2007. PMID: 17766046 Free PMC article.
-
Serotonergic Drugs for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Review of Past Development, Pitfalls and Failures, and a Look to the Future.Psychopharmacol Bull. 2024 Aug 19;54(4):45-80. Psychopharmacol Bull. 2024. PMID: 39263202 Free PMC article. Review.
-
Venlafaxine extended-release: a review of its use in the management of major depression.CNS Drugs. 2001;15(8):643-69. doi: 10.2165/00023210-200115080-00007. CNS Drugs. 2001. PMID: 11524036 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
